Parse Biosciences Evercode Whole Transcriptome Version 3

Parse Biosciences has launched the Evercode Whole Transcriptome version 3, an update to its single-cell sequencing assays. The new version offers a more streamlined and flexible workflow, higher-throughput fixation, and improved sensitivity in gene detection. Specifically, the version 3 chemistry enables customers to fix up to 96 samples simultaneously in plate format, ideal for high-throughput drug screening or the profiling of patient samples from large cohorts, the company said. The product will be available to ship in mid-March.